Article
Differences in Clinical Manifestations and Tumor Features Between Metastatic Pheochromocytoma/Paraganglioma Patients With and Without Germline SDHB Mutation.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists - 1 Apr 2021
Cui Yunying, Ma Xiaosen, Wang Fen, Wang Huiping, Zhou Ting, Chen Shi, Tong Anli, Li Yuxiu
Abstract excerpt
OBJECTIVE: To compare metastatic pheochromocytoma/paraganglioma (MPP) patients with germline SDHB mutations (SDHB MPP) and without SDHB mutations (non-SDHB MPP) in terms of baseline clinical manifestations, tumor characteristics, and outcomes. METHODS: Clinical data were retrospectively reviewed in 101 MPP patients, including 34 SDHB MPP patients and 61 non-SDHB MPP patients. RESULTS: SDHB MPP patients presented...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.